Gentronix Ltd Details

Gentronix Ltd

Company Profile:
Gentronix provides services and solutions that help companies reduce attrition rates and ensure safer products across a wide range of chemistry driven industries. Our primary focus is on providing better hazard identification assays for genotoxicity through use of GreenScreen® human cell technology. GreenScreen HC and HC S9 assays are designed for use much earlier in drug and compound discovery than the standard battery of genotoxicity tests and provide positive results that are more accurately predictive of in-vivo risk than the current in-vitro mammalian assays.

Previous Clients:
Gentronix provides assay ready kits and CRO services to over 50 pharmaceutical and biotechnology companies worldwide. Our philosophy of scientific excellence coupled with expert customer support provides our partners with excellent resources to meet their critical attrition rate reduction goals.

Key Products:
GreenScreen HC is available in three formats:

• Convenient ‘ready to use' kits
• Annual licences for larger users
• Outsourced testing service

Developed in a simple microplate format requiring only 1mg of compound, the assay is easily automated using standard laboratory equipment. Published results and trial data demonstrate a unique combination of exceptionally high specificity and sensitivity making GreenScreen HC the first in-vitro mammalian cell assay truly suitable for early candidate screening.

Earlier this year Gentronix launched GreenScreen HC S9 to provide detection of genotoxic metabolites. Using flow cytometry detection this assay offers the same ease of use as the HC assay.

Website:
www.gentronix.co.uk